← Open Payments lookup

SUKI PARKS: Open Payments

NPI 1619002508 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$293 in 12 payments from 9 companies in 2025. Trend: 2023 $259 · 2024 $292 · 2025 $293

Food & beverage: $293
CompanyPaymentsAmount
Exelixis Inc.2$58
Azurity Pharmaceuticals, Inc.2$42
AstraZeneca Pharmaceuticals LP2$41
Regeneron Healthcare Solutions, Inc.1$33
ABBVIE INC.1$27
Lilly USA, LLC1$26
Merck Sharp & Dohme LLC1$26
Incyte Corporation1$26
Janssen Biotech, Inc.1$14

Products named: CABOMETYX, CALQUENCE, LIBTAYO, IMBRUVICA, VERZENIO, KEYTRUDA, MONJUVI, VIVIMUSTA.

Industry payments across MD — which companies pay providers there.